Inhibitors of hepatitis C virus
The invention relates to compounds of Formula IV:IV,as well as pharmaceutically acceptable salts thereof and pharmaceutical compositions containing such compounds. The invention also relates to medical uses of said compounds and a method of treating hepatitis C virus infection. Invenţia se referă la...
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English Romanian Russian |
Published |
30.11.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to compounds of Formula IV:IV,as well as pharmaceutically acceptable salts thereof and pharmaceutical compositions containing such compounds. The invention also relates to medical uses of said compounds and a method of treating hepatitis C virus infection.
Invenţia se referă la compuşi cu formula IV:IV,precum şi la sărurile acceptabile farmaceutic ale acestora şi la compoziţii farmaceutice care conţin aceşti compuşi. Invenţia se referă, de asemenea, la utilizări medicale a acestor compuşi şi la o metodă de tratament al infecţiei cu virusul hepatitei C.
Изобретение относится к соединениям формулы IV:IV,а также к их фармацевтически приемлемым солям и к фармацевтическим композициям, содержащим эти соединения. Изобретение также относится к медицинским применениям указанных соединений и к способу лечения инфекции вируса гепатита С. |
---|---|
Bibliography: | Application Number: MD20140000136 |